Navigation Links
Fatty acid metabolite shows promise against cancer in mice
Date:4/2/2013

wound healing, while the EDPs block the growth and metastasis of solid tumors.

"Our results designate EDPs and EETs as unique mediators of an angiogenic switch to regulate tumorigenesis," Ferrara said. "They also implicate a novel mechanistic linkage between omega-3 and omega-6 fatty acids and cancers."

UC Davis scientists determined that EDP starves tumors by inhibiting vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2)-induced angiogenesis in mice. In laboratory cultures, EDP also suppresses the endothelial cell migration needed for new blood vessels.

Thus, EDP-based angiogenesis inhibitors offer an advantage over angiogenesis inhibitors that target the VEGF-VEGFR2 pathway. The drugs that target the VEGF-VEFGFR2 pathway increase patients' risk for high blood pressure.

Because EDPs widen the blood vessels, a medication based on the UC Davis researchers' discovery should not increase the patient's risk for high blood pressure.

Harvard researchers Mark Kieran and Dipak Panigrahy conducted the metastasis studies. The in vivo imaging work that allowed the scientists to monitor tumors in living mice was done in Ferrara's UC Davis laboratory.


'/>"/>

Contact: Dorsey Griffith
dorsey.griffith@ucdmc.ucdavis.edu
916-734-9118
University of California - Davis Health System
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Cellular renewal process may underlie benefits of omega fatty acids
2. Could ending your fatty food habit cause withdrawal symptoms and depression?
3. UCSB anthropologists finds high levels of omega-3 fatty acids in breast milk of Amerindian women
4. Cellular secrets of plant fatty acid production understood
5. Gut microbiota transplantation may prevent development of diabetes and fatty liver disease
6. Researchers unravel genetic mechanism of fatty liver disease in obese children
7. Cancer scientists link ‘oncometabolite’ to onset of acute myeloid leukemia
8. Appetite genes are key to better diets for poultry, study shows
9. Study shows resources giveaway in Latin America; Outdated model tramples human rights, environment
10. UF study shows spiders, not birds, may drive evolution of some butterflies
11. Study shows how one insect got its wings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its new ... G2 model. The G2 sets a higher standard for collecting ... capital management solution. With plug-and-play installation, touch screen interface and ... provides a robust time collection solution for the small to ...
(Date:12/22/2014)... 22, 2014  The 2014 Holiday Season may be the ... Intelligence reports that the long anticipated floodgates for consumer ... demand for smart phones, tablets, and wearable mobile devices ... 2.5 billion users with nearly 4.8 billion biometric devices ...
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... University School of Medicine studies of Hispanic farmworkers in North ... had skin disease and that workers need more information about ... deadly diseases such as skin cancer. , Few studies have ... Wake Forest studies, 59 farmworkers from Nash and Johnston Counties ...
... most effective chemotherapy drugs against cancer is cisplatin because ... it also kills healthy tissue. Many scientists are creating ... treatments without side effects. One approach to analog development ... a Virginia Tech chemistry-biology research team that has been ...
... ensure complete tumor removal at breast cancer excision is ... used light waves in a newly explored region of ... and determine if the removed tissue margins were clear ... potential to eliminate the need for multiple surgeries and ...
Cached Biology News:Skin disease common among Hispanic farmworkers in North Carolina, research shows 2Light activated anticancer drug targeted to DNA using cisplatin like sub-units 2Terahertz imaging may reduce breast cancer surgeries 2
(Date:1/22/2015)... 22 de enero de 2015  El Dr. Paul ... llamada a nominaciones para 2015. Este prestigioso premio reconoce ... tiene el potencial para hacer, contribuciones destacadas para la ... hasta el 15 de marzo de 2015 a través ...
(Date:1/22/2015)... 22, 2015   GenoSpace , a precision medicine software company ... the broad use of genomic, imaging and other biomedical data ... Michelle Munson , CEO of Aspera, an IBM Company, ... - http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... BOTHELL, Wash. , Dec. 24, 2014   BioLife Solutions ... manufacturer and marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" or ... Annual Meeting of Stockholders on May 4, 2015 (the "Annual ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... will be one of the presenters at Digestive Disease ... in interventional gastroenterologyORANGEBURG, S.C., May 29 Zeus, Inc., ... it has been invited to present at Digestive Disease ... Dr. Bruce Anneaux, Ph.D. and GI Endoscopy Specialist Aubrey ...
... May 29 Dey L.P., a subsidiary of Mylan ... it has begun to market and distribute EMSAM(R) in ... monoamine oxidase inhibitor (MAOI), which was approved by the ... the treatment of major depressive disorder. EMSAM previously was ...
... have designed cells that can count and "remember" cellular events, ... activated in a specific order. , Such circuits, which mimic ... the number of times a cell divides, or to study ... biosensors that count exposures to different toxins. , The team ...
Cached Biology Technology:Zeus to Present at Digestive Disease Week in Chicago 2Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder 2MIT, BU engineer cellular circuits that count events 2MIT, BU engineer cellular circuits that count events 3
Human RXR beta/NR2B2 MAb (Clone H7341) Keywords: RXRbeta, RXRbeta, Retinoid X Receptor beta...
Human SOST Affinity Purified Polyclonal Ab...
BOND ELUT MATRIX-C18, 25 mg ...
Prepared from plasminogen by activation with immobilized human uPA...
Biology Products: